The short-term mortality of PE also varies widely, ranging from less than 1% in hemodynamically stable patients with non-massive PE and no signs of right heart overload to over 90% in patients who present with cardiorespiratory arrest [1].
The use of a single infusion or repeated infusions also needs to be addressed, even though multiple infusions could lead to right heart overload (and pulmonary hypertension) [ 27].
Decreased pleural pressure has been shown to be associated with cardiovascular failure during weaning [ 74], possibly because of increased trans-diaphragmatic pressure and right heart overload [ 75].
The study was designed to compare RV morphological and functional parameters derived from conventional and myocardial deformation echocardiography in two instances of right heart pressure overload: pulmonary arterial hypertension (PAH) and pulmonary stenosis (PS).
The production of NT-proBNP is stimulated by heart volume overload secondary to systolic dysfunction.
Measures of association ranged from 11%% (MACE) to 20%% (heart failure/volume overload).
In summary, the current analysis has demonstrated potent and independent associations between greater IDWG and risk of CV events, particularly hospitalization for heart failure/volume overload and mortality.
Upon multivariable adjustment, estimates were mildly potentiated; significant adjusted associations were observed for all-cause mortality (7 % greater risk), heart failure/volume overload (14%% greater risk), and MACE+ (14%% greater risk).
Outcomes included all-cause mortality, CV mortality, hospitalization for nonfatal heart failure/volume overload, hospitalization for nonfatal myocardial infarction, MACE (a composite measure of nonfatal myocardial infarction, nonfatal ischemic stroke, or CV death), and MACE+ (events comprising MACE as well as arrhythmia, nonfatal hemorrhagic stroke, or hospitalization for heart failure).
The M-V ratio, however, lacks a well-defined normal reference range, and distributions that have been determined from healthy volunteers without co-existent coronary artery disease, hypertension, or other forms of congestive heart disease/fluid overload may not apply to those on dialysis.
Inhibition of Rho-kinase displays vasodilation property although its effect on cardiac remodeling in heart against pressure overload and ischemia has not been fully elucidated.
